FORMULATION AND EVALUATION OF NAPROXEN-EUDRAGIT® RS 100 NANOSUSPENSION USING 32 FACTORIAL DESIGN

Authors

  • M. Mothilal Department of Pharmaceutics, SRM College of Pharmacy, SRM University, Kattankulathur 603203, Tamilnadu, India.
  • M. chaitanya Krishna Department of Pharmaceutics, SRM College of Pharmacy, SRM University, Kattankulathur 603203, Tamilnadu, India.
  • S. p. surya Teja Department of Pharmaceutics, SRM College of Pharmacy, SRM University, Kattankulathur 603203, Tamilnadu, India.
  • V. Manimaran Department of Pharmaceutics, SRM College of Pharmacy, SRM University, Kattankulathur 603203, Tamilnadu, India.
  • N. Damodharan Department of Pharmaceutics, SRM College of Pharmacy, SRM University, Kattankulathur 603203, Tamilnadu, India.

Keywords:

Nanosuspension, Naproxen, Eudragit

Abstract

Objective: The objective of the present investigation was to develop drug loaded Eudragit® RS100 nanosuspension as a sustained release carrier.

Methods: All the nanosuspensions of Naproxen loaded Eudragit® RS100 were prepared using the quasi emulsion solvent diffusion technique at different drug: polymer ratios. The formulation was optimized using design of experiments by employing a 2-factor, 3-level factorial design. The drug: polymer ratio (X1) and speed of homogenization(X2), were the independent variables; particle size (Y1), zeta potential (Y2) and entrapment efficiency (Y3) as dependent variables. The nanosuspensions were studied for particle size analysis, X-ray diffraction analysis and surface morphology by scanning electron microscopy. The in vitro release study of Naproxen from nanosuspension was carried out using dialysis bag with molecular weight cut-off value of 12,000 to 14,000 Daltons.

Results: Average particle size of nanosuspension was between 159 to 435nm and zeta potential ranges from 20.7 to 53.5 mV. The statistical analysis of data revealed that drug: polymer ratio(X1) has a significant positive influence on particle size (p=0.0077) whereas a negative influence on zeta potential (p=0.0045) and Entrapment efficiency (p=0.0003). The developed model was validated using two check point formulations and found no significant difference between the predicted and observed values. An optimized formulation was also identified during the study.

Conclusion: This investigation demonstrated the potential of the experimental design in understanding the effect of formulation variables on the development of Nanosuspensions. The results assures, nanosuspension are promising sustained release system to the naproxen and many other drugs.

Downloads

Download data is not yet available.

References

Sankar V, Madhura KL, Nilaykumar P. Formulation and in-vitro evaluation of Zidovudine-lamivudine nanoparticles. Indian J Pharm Edu Res, 2012;46(2):192-196.

Pooja S, Anuj C, Sandeep A, Pravin P. Novel drug delivery approaches on antiviral and antiretroviral agents. J Adv Pharm Technol Res 2012;3:147–159.

Pignatello RA, Bucolo BC, Spedalieri AG, Maltese BA, Puglisi G. Flurbiprofen-Loaded Acrylate Polymer Nanosuspensions For Ophthalmic Application. Biomaterials 2002;23:3247–3255.

Manasa M, Manimaran N, J. Mothilal Damodharan Shaik Nelofar. Development Evaluation of Aceclofenac Nanosuspension Using Eudragit Rs100 Asian and Pharm Res 2 2012.

Yogeshkumar N. Gavhane, Adhikrao V. Yadav. Improvement In Physicochemical Properties Of Aceclofenac By Using Chitosan And Water Soluble Chitosan. Int J Pharm Pharm Sci, 2013;5(1), 414-419.

Hawkey CJ. Best Pract. Res. Clin. Gastroenterol. 2001;15:801.

Bombardier C, Laine L, Reicin A, Shapiro D, Davis B, Day R, Ferraz M B, Hawkey CJ, Schnitzer TJ, New Engl. J. Med. 2000;34:1520.

Azza AH. Formulation and Evaluation of Dorzolamide Hydrochloride-Loaded Nanoparticles as Controlled Release Drug Delivery System. Asian J Pharm. 2012;6:67-73.

Cooper J, Gunn C. Tutorial pharmacy. 6th ed. New Delhi. CBS Publishers and Distributors;1986;225.

Hadjiioannou TP, Christian GD, Koupparis MA. Quantitative calculation in pharmaceutical practice and research. 3rd.ed. New York:VCH Publishers;1993:345-348.

Higuchi T. Mechanism of Sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963:52:1145-1149.

Korsmeyer RW, Gunny R, Docler E, Buri P, Peppas NA. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25-35.

Shato H, Miyagawa Y, Okabe T, Miyajima M, Suanada H. Dissolution mechanism of diclofenac sodium from wax matrix granules. J Pharm. Sci 1997;86:929-934.

Adibkia, K, Siahi Shadbad MR, Nokhodchi A, Javadzedeh A, Barzegar-Jalali M, Barar J et al. Piroxicam nanoparticles for ocular delivery:physicochemical characterization and implementation in endotoxin-induced uveitis. J Drug Target 2007;15:407–416.

Adibkia K, Omidi Y, Siahi M.R, Javadzadeh AR, Barzegar JM, Barar J et al. Inhibition of endotoxin-induced uveitis by methylprednisolone acetate nanosuspension in rabbits. J Ocul Pharmacol Ther 2007;23:421–432.

Vijayan V, D.Srinivasa R, Jayachandran E, Anburaj J. Preparation and Characterization Of Anti Diabetic Drug Loaded Solid Lipid Nanoparticles. JITPS 2010;1:320-328.

Published

01-07-2014

How to Cite

Mothilal, M., M. chaitanya Krishna, S. p. surya Teja, V. Manimaran, and N. Damodharan. “FORMULATION AND EVALUATION OF NAPROXEN-EUDRAGIT® RS 100 NANOSUSPENSION USING 32 FACTORIAL DESIGN”. International Journal of Pharmacy and Pharmaceutical Sciences, vol. 6, no. 7, July 2014, pp. 449-55, https://www.innovareacademics.in/journals/index.php/ijpps/article/view/1740.

Issue

Section

Original Article(s)